Brain diseases such as Alzheimer’s and Parkinson’s are among the hardest conditions to treat, because so few medicines can reach the brain. Kurve exists to close that gap. Our nose-to-brain technology has been used in 22 human clinical trials and featured in 27 published studies, and we’re working to turn the tide on CNS disease.
So few medicines can reach the brain that diseases like Alzheimer’s and Parkinson’s remain among the hardest conditions to treat. Kurve exists to close that gap, delivering medication nose-to-brain through a simple, non-invasive device.
human clinical trials have used our nose-to-brain technology
published studies feature our technology
complete, with preparation for phase 3
Our mission is to help as many people as we possibly can in their fight with systemic and neurodegenerative disorders. Our hope is that these complex debilitating disorders may have a solution when paired with the right medication and the right technology. Our goal is to enhance the quality of life for patients and provide a solution where their past treatments have failed them–to give people a renewed sense of hope for the future.
ViaNase™ is available through Kurve’s clinical studies and FDA expanded access (compassionate use). Tell us who you are and we’ll guide you to the right route.
